Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Merck & Co., Inc. Insider Profile
18 Followers
Merck & Co., Inc., Ten Percent Owner at OpGen, holds 1.00K shares in Harpoon Therapeutics (Ticker: HARP), holds 12.96M shares in NGM Biopharmaceuticals (Ticker: NGM), holds 2.72M shares in Sutro Biopharma (Ticker: STRO).
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-26.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Merck & Co., Inc. holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 09, 2019 - Apr 09, 2020
Return:-8.00%
The most profitable trade made by Merck & Co., Inc.
Merck & Co., Inc.'s Trading History
OpGen
Jun 29, 2016
Ten Percent Owner
Uninformative Buy
―
$782.40K
Sutro Biopharma
Oct 02, 2018
Ten Percent Owner
Informative Buy
10.00M
$12.72M
NGM Biopharmaceuticals
Apr 09, 2019
Ten Percent Owner
Uninformative Buy
―
$19.82M
Harpoon Therapeutics
Mar 11, 2024
Ten Percent Owner
Uninformative Buy
492.14M
$23.01K
List of latest transactions for each holding click on a transaction to see Merck & Co., Inc.'s performance on stock
You May Also Like
Merck & Co., Inc. insider profile FAQ
What is the percentage of profitable transactions made by Merck & Co., Inc.?
The percentage of profitable transactions made by Merck & Co., Inc. is 0%.
What is the average return per transaction made by Merck & Co., Inc.?
The average return per transaction made by Merck & Co., Inc. is -26.50%.
What stocks does Merck & Co., Inc. hold?
Merck & Co., Inc. holds: OPGN, STRO, NGM, HARP stocks.
What was Merck & Co., Inc.’s latest transaction?
Merck & Co., Inc. latest transaction was an Uninformative Buy of $492.14M.
What was Merck & Co., Inc.'s most profitable transaction?
Merck & Co., Inc.’s most profitable transaction was an Informative Buy of NGM stock on April 9, 2019. The return on the trade was -8.00%.
What is Merck & Co., Inc.'s role in OpGen?
Merck & Co., Inc.'s role in OpGen is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.